Literature DB >> 2778779

Lymphopenia in rheumatoid arthritis.

D P Symmons1, M Farr, M Salmon, P A Bacon.   

Abstract

Lymphopenia is a recognized but poorly studied feature of rheumatoid arthritis (RA). We set out to establish the prevalence and significance of lymphopenia in RA. A group of 66 RA patients was studied for one year. During this time 10 (15%) had persistent lymphopenia (lymphocyte count less than 1.00 X 10(9)/l) without evidence of Felty's syndrome. A separate study of lymphocyte subsets in 13 lymphopenic RA patients showed marked reduction in T-cell numbers with normal circulating B-cell numbers. The numbers of CD4 and CD8 positive T-cells were equally depressed. Lymphopenia may indicate more severe disease. It was not influenced by changes in disease activity or therapy.

Entities:  

Mesh:

Year:  1989        PMID: 2778779      PMCID: PMC1292249          DOI: 10.1177/014107688908200806

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  10 in total

Review 1.  The immunopathology of joint inflammation in rheumatoid arthritis.

Authors:  N J Zvaifler
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

2.  Failure to show a fall in peripheral blood lymphocytes in patients receiving gold or penicillamine for rheumatoid arthritis.

Authors:  M Ishigami; A J Chuck; A J Swannell; M Doherty; K Gordon
Journal:  Ann Rheum Dis       Date:  1987-03       Impact factor: 19.103

3.  The use of cytocentrifuge preparations for the demonstration of T cell surface antigens.

Authors:  M Salmon; P A Bacon; G D Johnson; L Walker; K W Walton
Journal:  J Immunol Methods       Date:  1984-02-10       Impact factor: 2.303

4.  Transferrin receptor bearing cells in the peripheral blood of patients with rheumatoid arthritis.

Authors:  M Salmon; P A Bacon; D P Symmons; A D Blann
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

5.  Characterisation of activated lymphocytes in the peripheral blood of patients with rheumatoid arthritis.

Authors:  S D Carter; P A Bacon; N D Hall
Journal:  Ann Rheum Dis       Date:  1981-06       Impact factor: 19.103

6.  Synovial fluid lymphocytes differ from peripheral blood lymphocytes in patients with rheumatoid arthritis.

Authors:  R I Fox; S Fong; N Sabharwal; S A Carstens; P C Kung; J H Vaughan
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

7.  Analysis of T cell subsets in the peripheral blood and synovial fluid of patients with rheumatoid arthritis by means of monoclonal antibodies.

Authors:  O Duke; G S Panayi; G Janossy; L W Poulter; N Tidman
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

8.  Reduction of peripheral blood lymphocytes in patients receiving gold therapy for rheumatoid arthritis.

Authors:  J G Hanly; B Bresnihan
Journal:  Ann Rheum Dis       Date:  1985-05       Impact factor: 19.103

9.  Sulfasalazine treatment and lymphocyte function in patients with rheumatoid arthritis.

Authors:  D P Symmons; M Salmon; M Farr; P A Bacon
Journal:  J Rheumatol       Date:  1988-04       Impact factor: 4.666

10.  An immunohistological analysis of lymphocyte subpopulations and their microenvironment in the synovial membranes of patients with rheumatoid arthritis using monoclonal antibodies.

Authors:  O Duke; G S Panayi; G Janossy; L W Poulter
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

  10 in total
  6 in total

1.  The association between the lymphocyte-monocyte ratio and disease activity in rheumatoid arthritis.

Authors:  Juping Du; Shuaishuai Chen; Jianfeng Shi; Xiaoli Zhu; Haijian Ying; Ying Zhang; Shiyong Chen; Bo Shen; Jun Li
Journal:  Clin Rheumatol       Date:  2017-09-14       Impact factor: 2.980

2.  The Association Between Neutrophil/Lymphocyte Ratio and Disease Activity in Rheumatoid Arthritis and Ankylosing Spondylitis.

Authors:  Ridvan Mercan; Berivan Bitik; Abdurrahman Tufan; Utku Burak Bozbulut; Nuh Atas; Mehmet Akif Ozturk; Seminur Haznedaroglu; Berna Goker
Journal:  J Clin Lab Anal       Date:  2015-12-14       Impact factor: 2.352

3.  CD11c-mediated deletion of Flip promotes autoreactivity and inflammatory arthritis.

Authors:  Qi-Quan Huang; Harris Perlman; Robert Birkett; Renee Doyle; Deyu Fang; G Kenneth Haines; William Robinson; Syamal Datta; Zan Huang; Quan-Zhen Li; Hyewon Phee; Richard M Pope
Journal:  Nat Commun       Date:  2015-05-12       Impact factor: 14.919

Review 4.  How to interpret and pursue an abnormal complete blood cell count in adults.

Authors:  Ayalew Tefferi; Curtis A Hanson; David J Inwards
Journal:  Mayo Clin Proc       Date:  2005-07       Impact factor: 7.616

5.  Cross-Tissue Transcriptomic Analysis Leveraging Machine Learning Approaches Identifies New Biomarkers for Rheumatoid Arthritis.

Authors:  Dmitry Rychkov; Jessica Neely; Tomiko Oskotsky; Steven Yu; Noah Perlmutter; Joanne Nititham; Alexander Carvidi; Melissa Krueger; Andrew Gross; Lindsey A Criswell; Judith F Ashouri; Marina Sirota
Journal:  Front Immunol       Date:  2021-06-08       Impact factor: 8.786

6.  Changes in selected haematological parameters associated with JAK1/JAK2 inhibition observed in patients with rheumatoid arthritis treated with baricitinib.

Authors:  Jonathan Kay; Masayoshi Harigai; Josh Rancourt; Christina Dickson; Thomas Melby; Maher Issa; Inmaculada de la Torre; Yoshitaka Isaka; Anabela Cardoso; Chadi Saifan; Edward C Keystone; Ronald F van Vollenhoven; Jon T Giles; Tom Wj Huizinga; Joel M Kremer
Journal:  RMD Open       Date:  2020-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.